AstraZeneca PLC (NAS:AZN)
$ 67.62 0.42 (0.63%) Market Cap: 208.85 Bil Enterprise Value: 235.48 Bil PE Ratio: 32.60 PB Ratio: 5.34 GF Score: 92/100

Q4 2023 AstraZeneca PLC Earnings Call Transcript

Feb 08, 2024 / 11:45AM GMT
Release Date Price: $63.52 (-4.55%)
Andrew P. Barnett
AstraZeneca PLC - Head of IR

Well, a warm welcome, everybody, to AstraZeneca's Fourth quarter and full year '23 results presentation conference call and webcast for investors and analysts. I'm Andy Barnett, Head of Investor Relations. And before I hand over to Pascal and members of the executive team, I'd like to cover some important housekeeping points.

Firstly, as I'm probably sure you realize all the materials are already on our website for your review. Here is our forward-looking statement, which I'd encourage you to take the time to read. We'll be making comments on our performance using constant exchange rates, or CER, core financial numbers and other non-GAAP measures and non-GAAP to GAAP reconciliation is contained within the results announcement that you all have seen. All numbers quoted are in millions of U.S. dollars unless otherwise stated.

This slide shows the agenda for today's call. Following our prepared remarks, we'll open the line for questions. Of course, if you want to raise a -- ask a question in the room, you raise your hands, there'll be roving

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot